Inspire Medical's Earnings Surge in Q4
The sleep apnea specialist's fourth-quarter results surpassed expectations.
Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate. Revenue climbed to $239.7 million, exceeding the forecast of $236 million.
Source: Analysts' estimates for the quarter provided by FactSet.
Inspire Medical Systems is a leader in neurostimulation technology for obstructive sleep apnea; its devices are the only ones of their type with FDA approval. The company is now focused on expanding its geographical reach and product offerings. Its strong clinical data and high patient satisfaction have been key factors to its success, as they are crucial for securing insurance reimbursements and driving adoption rates.
